ICCM | IceCure Medical Ltd Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	1.2900 - 1.3500
52 Week Range	0.4800 - 1.6600
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	69,125
Average Volume	404,027
Shares Outstanding	56,569,000
Market Cap	76,368,150
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2021-08-26

Valuation
Profitability
Growth
Health
P/E Ratio	-4.82
Forward P/E Ratio	N/A
EPS	-0.28
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	71
Country	Israel
Website	ICCM

IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

ICCM's peers: BRSYF, OSA, SRDX, SSKN, TNON, BWAY, PETV, SINT, CTSO, NPCE, CLPT, TELA, KIDS, CNMD, ITGR, SGHT, TMCI, ESTA

*Chart delayed

Analyzing fundamentals for ICCM we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see ICCM Fundamentals page.

Watching at ICCM technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on ICCM Technicals page.